Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BL-M14D1 |
| Trade Name | |
| Synonyms | BL M14D1|BLM14D1 |
| Drug Descriptions |
BL-M14D1 is an antibody-drug conjugate (ADC) targeting DLL3, which potentially induces antitumor activity (J Clin Oncol 2026 44:16_Suppl, 3001). |
| DrugClasses | DLL3 Antibody 11 |
| CAS Registry Number | NA |
| NCIT ID | C223897 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + BL-M14D1 | Atezolizumab BL-M14D1 | 0 | 1 |
| BL-M14D1 | BL-M14D1 | 0 | 1 |